6-Bromomethyl-nicotinic acid ethyl ester, 95.0%, 5g

Dipropylene glycol monopropyl ether, min 98%, for synthesis, 1L, plastic packaging.

(R)-4-Isopropyloxazolidin-2-one, 95.0%, 1g

tert-Butyl (4aS,9bR)-8-fluoro-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3-b]indole-2-carboxylate, 95%, 1g

2-Bromo-4-iodobenzaldehyde, 95.0%, 1g

Methyl 2-(4-aminopiperidine-1-carbonyl)benzoate hydrochloride, 95.0%, 1g

4-BROMO-2-(TERT-BUTYL)-5-METHYLPHENOL, 95.0%, 1g

5-Bromo-1-cyclopropyl-1H-pyrazole, 98%, 1g

4,5-DICHLORO-1,2-DIMETHYL-1H-IMIDAZOLE, 95%, 1g

3,4-DIHYDRO-1-ISOPROPYLISOQUINOLINE-7-CARBALDEHYDE, 95.0%, 250mg

[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-5-CARBOXYLIC ACID, 95.0%, 10g

alpha-D-Galactose pentaacetate, 95.0%, 25g

FANANSERIN, 95%, 10mg